1022 related articles for article (PubMed ID: 22512677)
21. Narrow band UVB (311 nm) phototherapy and PUVA photochemotherapy: a combination.
Calzavara-Pinton P
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):687-90. PubMed ID: 9591811
[TBL] [Abstract][Full Text] [Related]
22. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
23. Home Narrowband Ultraviolet B Phototherapy for Photoresponsive Skin Conditions: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(12):1-134. PubMed ID: 33240453
[TBL] [Abstract][Full Text] [Related]
24. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
[TBL] [Abstract][Full Text] [Related]
25. Soluble tumour necrosis factor-alpha receptor type 1 as a biomarker of response to phototherapy in patients with psoriasis.
Serwin AB; Chodynicka B
Biomarkers; 2007; 12(6):599-607. PubMed ID: 17852084
[TBL] [Abstract][Full Text] [Related]
26. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis.
Amornpinyokeit N; Asawanonda P
Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):285-9. PubMed ID: 17100735
[TBL] [Abstract][Full Text] [Related]
27. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
Karaosmanoglu N; Ozdemir Cetinkaya P; Kutlu O; Karaaslan E; Imren IG; Kiratli Nalbant E; Eksioglu M
Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
[TBL] [Abstract][Full Text] [Related]
28. Systematic review of UV-based therapy for psoriasis.
Almutawa F; Alnomair N; Wang Y; Hamzavi I; Lim HW
Am J Clin Dermatol; 2013 Apr; 14(2):87-109. PubMed ID: 23572293
[TBL] [Abstract][Full Text] [Related]
29. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis.
Markham T; Rogers S; Collins P
Arch Dermatol; 2003 Mar; 139(3):325-8. PubMed ID: 12622624
[TBL] [Abstract][Full Text] [Related]
30. Topical 8-methoxypsoralen enhances the therapeutic results of targeted narrowband ultraviolet B phototherapy for plaque-type psoriasis.
Asawanonda P; Amornpinyokeit N; Nimnuan C
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):50-5. PubMed ID: 18181973
[TBL] [Abstract][Full Text] [Related]
31. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
Lindelöf B
Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
[TBL] [Abstract][Full Text] [Related]
32. A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy.
Ibbotson SH
Front Med (Lausanne); 2018; 5():184. PubMed ID: 30013973
[TBL] [Abstract][Full Text] [Related]
33. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
34. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis.
Almutawa F; Thalib L; Hekman D; Sun Q; Hamzavi I; Lim HW
Photodermatol Photoimmunol Photomed; 2015 Jan; 31(1):5-14. PubMed ID: 24283358
[TBL] [Abstract][Full Text] [Related]
36. Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with fitzpatrick skin type IV.
Khurshid K; Haroon TS; Hussain I; Pal SS; Jahangir M; Zaman T
Int J Dermatol; 2000 Nov; 39(11):865-7. PubMed ID: 11123453
[TBL] [Abstract][Full Text] [Related]
37. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
Stern RS; Laird N
Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
[TBL] [Abstract][Full Text] [Related]
38. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of narrowband UVB phototherapy and psoralen plus UVA photochemotherapy in the treatment of generalized lichen planus: Results from a large retrospective analysis and an update of the literature.
Weber B; Marquart E; Radakovic S; Tanew A
Photodermatol Photoimmunol Photomed; 2022 Mar; 38(2):104-111. PubMed ID: 34351641
[TBL] [Abstract][Full Text] [Related]
40. Frequency of phototherapy for treating psoriasis: a systematic review.
Damiani G; Pacifico A; Chu S; Chi CC;
Ital J Dermatol Venerol; 2022 Jun; 157(3):215-219. PubMed ID: 33982550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
